Topiroxostat

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Topiroxostat.svg
Systematic (IUPAC) name
4-[5-(4-Pyridinyl)-1H-1,2,4-triazol-3-yl]-2-pyridinecarbonitrile
Clinical data
Trade names Topiloric, Uriadec
Legal status
  • Approved in Japan
Identifiers
CAS Number 577778-58-6
ATC code None
PubChem CID: 5288320
ChemSpider 4450517
Chemical data
Formula C13H8N6
Molecular mass 248.24 g/mol
  • C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N
  • InChI=1S/C13H8N6/c14-8-11-7-10(3-6-16-11)13-17-12(18-19-13)9-1-4-15-5-2-9/h1-7H,(H,17,18,19)
  • Key:UBVZQGOVTLIHLH-UHFFFAOYSA-N

Topiroxostat (INN; trade names Topiloric, Uriadec) is a drug for the treatment of gout and hyperuricemia.[1] It was approved for use in Japan in June 2013.[1]

Topiroxostat is a xanthine oxidase inhibitor which reduces serum urate levels.[2]

References

  1. ↑ 1.0 1.1 Lua error in package.lua at line 80: module 'strict' not found.
  2. ↑ Lua error in package.lua at line 80: module 'strict' not found.



<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.
Retrieved from "https://infogalactic.com/w/index.php?title=Topiroxostat&oldid=713250801"